Bart Friedman - 20 Feb 2025 Form 4 Insider Report for Ovid Therapeutics Inc. (OVID)

Role
Director
Signature
/s/ Jason Minio, Attorney-in-Fact
Issuer symbol
OVID
Transactions as of
20 Feb 2025
Net transactions value
$0
Form type
4
Filing time
18 Jun 2025, 16:45:09 UTC
Previous filing
16 Dec 2024
Next filing
02 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Friedman Bart Director C/O OVID THERAPEUTICS INC., 441 NINTH AVENUE, NEW YORK /s/ Jason Minio, Attorney-in-Fact 18 Jun 2025 0001368324

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OVID Stock Option (right to buy) Award $0 +45,000 $0.000000 45,000 20 Feb 2025 Common Stock 45,000 $0.5700 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option will vest in full on February 20, 2026, subject to the Reporting Person's continuous service through such vesting date.